42
Participants
Start Date
October 21, 2021
Primary Completion Date
October 21, 2022
Study Completion Date
May 21, 2023
Intraoperative infusion of 5-FU (200 µg/ml) and LMWH (5 IU/ml)
After informed consent, children under 14 years of age with high-risk PRRD underwent pars plana vitrectomy and silicone oil injection with scleral buckle divided into 2 groups in prospective randomized trial. Group A received intraoperative infusion of 5-FU (200 µg/ml) and LMWH (5 IU/ml).
Placebo
After informed consent, children under 14 years of age with high-risk PRRD underwent pars plana vitrectomy and silicone oil injection with scleral buckle divided into 2 groups in prospective randomized trial. Group B received infusion of normal saline.
Faculty of Medicine, Alexandria University, Alexandria
Alexandria University
OTHER